Encompass Health Corp (NYSE: EHC) has reported earnings for its fourth fiscal quarter (ending December 31) of $1.20 versus $0.96 for the same period a year ago — an increase of 25%. For the latest four quarters through December 31, E.P.S. were $4.56 versus $3.63 for the same period a year ago — an increase of 26%.
Recent Price Action
Encompass Health Corp (NYSE: EHC) stock closed at $98.60 on 2/6/25 after a decline of -3.5%. Moreover, unusually high trading volume at 176% of normal accompanied the decline. The stock has risen 3.2% during the last week and has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Encompass Health has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing contradictory signals. Encompass Health has a poor Appreciation Score of 21 but a slightly positive Power Rating of 67, triggering the Negative Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment